Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report

Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report

Abstract Background Hepatocellular carcinoma (HCC) is an aggressive malignancy with high morbidity and mortality. Conversion therapy can improve surgical resection rate and prolong survival time for patients with advanced HCC. We show that combination therapy with lenvatinib and camrelizumab is a no...

Full description

Bibliographic Details
Main Authors: Zhihong Chen, Zhenrong Chen, Wu Fan, Yiping Zou, Yuanpeng Zhang, Ning Shi, Haosheng Jin
Format: Article
Language:English
Published: BMC 2023-01-01
Series:World Journal of Surgical Oncology
Subjects:
Hepatocellular carcinoma
Conversion hepatectomy
Lenvatinib
Camrelizumab
Case report
Online Access:https://doi.org/10.1186/s12957-023-02910-4

Similar Items

Similar Items